Article Details
Retrieved on: 2024-03-18 18:59:44
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses how Johns Hopkins Medicine researchers are identifying early biomarkers for ALS and FTD, focusing on a cryptic exon-linked protein (HDGFL2) that correlates with TDP-43 function loss and could aid in early detection. Additionally, the study explores genetic links to these cognitive disorders by examining patients with C9orf72 mutations.
Article found on: www.hopkinsmedicine.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here